iifl-logo

Indo US Bio-Tech Ltd Cash Flow Statement

168.59
(-0.83%)
Apr 25, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Indo US Bio-Tech FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2019

Profit before tax

5.48

4.12

2.87

2.81

Depreciation

-0.43

-0.26

-0.22

-0.25

Tax paid

-0.25

0.97

-0.32

-0.72

Working capital

15.68

5.33

4.9

8.03

Other operating items

Operating

20.47

10.16

7.21

9.86

Capital expenditure

3.21

-0.49

0.24

0.06

Free cash flow

23.68

9.67

7.45

9.92

Equity raised

43.19

20.74

18.1

9.91

Investing

0

0.01

0

0

Financing

18.96

19.9

14.75

12.71

Dividends paid

0.15

0

0

0

Net in cash

85.99

50.32

40.31

32.54

Indo US Bio-Tech : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.